Lyrica (Pregabalin) - New Gabapentinoid with Wide

Specifications - Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application


Key Data
Drug (brand/generic)Lyrica / pregabalin
Company/licenseePfizer
Therapy classAntiepileptic
Product descriptionGABA analogue
Current indicationTreatment of neuropathic pain, adjunctive therapy in epilepsy and treatment of generalised anxiety disorder
Market sectorCNS, pain control
Development statusApproved for neuropathic pain in both Europe and the US and additionally for partial seizures in Europe


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?